BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33858227)

  • 21. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer.
    Tomisato S; Yamagami W; Susumu N; Kuwahata M; Takigawa A; Nomura H; Kataoka F; Hirasawa A; Banno K; Aoki D
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1733-9. PubMed ID: 24888941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
    Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
    Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer.
    Sun Y; Wang Y; Cheng X; Wu W; Liu Q; Chen X; Ren F
    Eur J Surg Oncol; 2024 Apr; 50(4):108260. PubMed ID: 38484492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for pelvic lymph node metastasis in endometrial cancer.
    Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
    Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
    Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
    Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
    El-Agwany AS; Meleis MH
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
    Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
    Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer.
    Zanfagnin V; Huang Y; Mc Gree ME; Weaver AL; Casarin J; Multinu F; Cappuccio S; Ferrero A; Mariani A; Glaser GE
    Gynecol Oncol; 2019 Sep; 154(3):480-486. PubMed ID: 31324453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel preoperative predictive score to evaluate lymphovascular space involvement in endometrial cancer: an aid to the sentinel lymph node algorithm.
    Capozzi VA; Sozzi G; Uccella S; Ceni V; Cianciolo A; Gambino G; Armano G; Pugliese M; Scambia G; Chiantera V; Berretta R
    Int J Gynecol Cancer; 2020 Jun; 30(6):806-812. PubMed ID: 32284322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors of Lymph Nodes Metastases by Endometrial Cancer: A Retrospective One-center Study.
    Muallem MZ; Sehouli J; Almuheimid J; Richter R; Joukhadar R; Plett H
    Anticancer Res; 2016 Aug; 36(8):4219-25. PubMed ID: 27466535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.
    Odagiri T; Watari H; Kato T; Mitamura T; Hosaka M; Sudo S; Takeda M; Kobayashi N; Dong P; Todo Y; Kudo M; Sakuragi N
    Ann Surg Oncol; 2014 Aug; 21(8):2755-61. PubMed ID: 24705578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
    Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
    Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
    Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical versus endometrial injection for sentinel lymph node detection in endometrial cancer: a randomized clinical trial.
    Gezer Ş; Duman Öztürk S; Hekimsoy T; Vural Ç; İşgören S; Yücesoy İ; Çorakçı A
    Int J Gynecol Cancer; 2020 Mar; 30(3):325-331. PubMed ID: 32029429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can we omit para-aorta lymph node dissection in endometrial cancer?
    Tanaka H; Sato H; Miura H; Sato N; Fujimoto T; Konishi Y; Takahashi O; Tanaka T
    Jpn J Clin Oncol; 2006 Sep; 36(9):578-81. PubMed ID: 16870694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Application of the two-step sentinel lymph node biopsy with double-tracer in early staged endometrial cancer].
    Wang YN; Xia YF; Chen YQ; Qi HY; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2022 Nov; 57(11):812-820. PubMed ID: 36456477
    [No Abstract]   [Full Text] [Related]  

  • 40. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
    Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
    Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.